eSTI2 chlamydia clinical care pathway pilot study
Research type
Research Study
Full title
Can internet-based (eSTI2) clinical care pathways for people with genital chlamydial infection provide an acceptable and feasible alternative to routine care?
IRAS ID
112513
Contact name
Claudia Estcourt
Contact email
Sponsor organisation
Barts Health NHS Trust
Research summary
The eSTI2 chlamydia clinical care pathway pilot study sits within the eSTI2 Consortium , which is a multidisciplinary collaboration of six major UK institutions funded by the UKCRC, to deliver a five year program of research which aims to reduce the impact of sexually transmitted infections (STIs) by developing, evaluating and deploying simple to use, rapid, accurate, polymicrobial and affordable micro-diagnostics that can be networked through mobile phones. These diagnostics may be deployed as self-tests (home tests), or within more traditional clinical settings.
Clinical management and follow up of individuals who test using these technologies will be possible using remote management pathways (eSTI2 chlamydia clinical care pathway) within “eSexual Health clinics”, embedded within NHS sexual health services. This could increase the treatment rate in people who test postive for STIs and reduce delays in accessing effective treatment.
The innovative nature of the remote management pathway means that extensive evaluation is necessary before trials of a putative eSTI2 diagnostic device are implemented. Therefore, we will undertake this exploratory study to further develop, implement and evaluate the eSTI2 chlamydia clinical care pathway with a view to detailed evaluation which will enable us to design a future large scale trial in which the eSTI2 device and clinical care pathway are integrated within a complex intervention.
REC name
London - Brighton & Sussex Research Ethics Committee
REC reference
13/LO/1111
Date of REC Opinion
13 Aug 2013
REC opinion
Favourable Opinion